欢迎访问《岭南现代临床外科》官方网站,今天是

岭南现代临床外科 ›› 2017, Vol. 17 ›› Issue (02): 230-235.DOI: 10.3969/j.issn.1009-976X.2017.02.025

• 综述 • 上一篇    下一篇

肝细胞癌生物标记物的研究进展

罗启杰 胡泽民   

  1. 中山市人民医院
  • 通讯作者: 胡泽民

Progress of biomarkers of hepatocellular carcinoma

LUO Qijie,HU Zemin   

  • Online:2017-04-20 Published:2017-04-20
  • Contact: HU Zemin

摘要:

原发性肝细胞癌(hepatocellularcarcinoma,HCC)是全世界第五大恶性肿瘤,早期诊断较困难,大多数患者就诊时已属中、晚期而错失最佳治疗时机,HCC的生物标志物对于HCC的早期诊断、监测肿瘤进展、疗效判定、复发和存活率的判定十分重要,本文就近年来发现的肝癌肿瘤标记物作一综述。

关键词: 肿瘤标志物, 肝细胞癌

Abstract:

Hepatocellular CarcinomaHCCis the worlds fifth malignant tumor. Most patients have been in advanced stage and missed the best treatment timing when they are diagnosed. The effective biomarkers are important for the early diagnosis the monitoring of tumor progression judgement of curative effectrecurrence and survival rate of judgement. This article reviewed the several biomarkers which have been found in the past few years.

Key words: biomarkers, hepatocellular carcinoma

中图分类号: